ViiV Healthcare has put forth a series of new initiatives to make HIV/AIDS treatment more accessible in poor countries, according to a ViiV statement. Its efforts include: offering generic manufacturers in those countries royalty-free voluntary licenses for all current and future ViiV products; cutting prices on drugs sold in those countries; and devoting millions of dollars toward research, treatment and care for infants and children with HIV/AIDS.

To read the ViiV statement, click here.